Publicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Lleida (13)

2024

  1. Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum

    Frontiers in Endocrinology, Vol. 15

2021

  1. Brafv600e mutant allele frequency (Maf) influences melanoma clinicopathologic characteristics

    Cancers, Vol. 13, Núm. 20

2020

  1. Adjuvant therapy for true ampullary cancer: a systematic review

    Clinical and Translational Oncology, Vol. 22, Núm. 8, pp. 1407-1413

  2. Characterisation of the inflammatory response triggered by topical ingenol mebutate 0.05% gel in basal cell carcinoma

    Australasian Journal of Dermatology, Vol. 61, Núm. 2, pp. e200-e207

  3. Eccrine carcinoma: two cases of an unusual carcinoma and a review of the literature

    Piel, Vol. 35, Núm. 3, pp. 159-165

2018

  1. Cytokeratin Profile of Basal Cell Carcinomas According to the Degree of Sun Exposure and to the Anatomical Localization

    American Journal of Dermatopathology, Vol. 40, Núm. 5, pp. 342-348

  2. Langerhans cell histiocytosis mimicking molluscum contagiosum: A case series

    Pediatric Blood and Cancer, Vol. 65, Núm. 7

  3. Severe and recurrent levamisole-induced cutaneous vasculopathy

    Journal of Cutaneous Pathology, Vol. 45, Núm. 4, pp. 309-311

2017

  1. Novel biomarkers in primary breast core biopsies to predict poor response to neoadjuvant chemotherapy and appearance of metastases

    Histology and Histopathology, Vol. 32, Núm. 9, pp. 909-915

  2. Topical Interferon Alpha-2b for Diffuse Conjunctival Primary Acquired Melanosis with Atypia

    Ocular Immunology and Inflammation

  3. Vulvar basal cell carcinoma: Four case reports with immunohistochemical study

    Journal of Cutaneous Medicine and Surgery, Vol. 21, Núm. 5, pp. 457-459

2016

  1. Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies

    Blood, Vol. 127, Núm. 15, pp. 1907-1911

2014

  1. Phosphorylation at ser-181 of oncogenic KRAS is required for tumor growth

    Cancer Research, Vol. 74, Núm. 4, pp. 1190-1199